Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 1431789, 11 pages
http://dx.doi.org/10.1155/2016/1431789
Research Article

Forskolin Inhibits Lipopolysaccharide-Induced Modulation of MCP-1 and GPR120 in 3T3-L1 Adipocytes through an Inhibition of NFB

1Laboratory of Pathophysiological and Nutritional Biochemistry, Université Libre de Bruxelles, Brussels, Belgium
2Department of Biochemistry, Faculty of Sciences, University of Dschang, Dschang, Cameroon
3Institute for Medical Immunology, Faculty of Medicine, Université Libre de Bruxelles, Gosselies, Belgium

Received 13 June 2016; Accepted 13 October 2016

Academic Editor: Julio Galvez

Copyright © 2016 Jeanne Durendale Chiadak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. K. E. Wellen and G. S. Hotamisligil, “Obesity-induced inflammatory changes in adipose tissue,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1785–1788, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Xu, G. T. Barnes, Q. Yang et al., “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821–1830, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Takahashi, S. Mizuarai, H. Araki et al., “Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice,” The Journal of Biological Chemistry, vol. 278, no. 47, pp. 46654–46660, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Sartipy and D. J. Loskutoff, “Monocyte chemoattractant protein 1 in obesity and insulin resistance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7265–7270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. E. Shoelson and A. B. Goldfine, “Getting away from glucose: fanning the flames of obesity-induced inflammation,” Nature Medicine, vol. 15, no. 4, pp. 373–374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Manickam, A. J. Sinclair, and D. Cameron-Smith, “Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes,” Lipids in Health and Disease, vol. 9, article 57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mullen, C. E. Loscher, and H. M. Roche, “Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages,” Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 444–450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. W. Hsueh, Z. Zhou, J. Whelan et al., “Stearidonic and eicosapentaenoic acids inhibit interleukin-6 expression in ob/ob mouse adipose stem cells via toll-like receptor-2-mediated pathways,” Journal of Nutrition, vol. 141, no. 7, pp. 1260–1266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. K. Murumalla, M. K. Gunasekaran, J. K. Padhan et al., “Fatty acids do not pay the toll: effect of SFA and PUFA on human adipose tissue and mature adipocytes inflammation,” Lipids in Health and Disease, vol. 11, article 175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Oliver, F. C. McGillicuddy, K. A. Harford et al., “Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA,” Journal of Nutritional Biochemistry, vol. 23, no. 9, pp. 1192–1200, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Y. Oh, S. Talukdar, E. J. Bae et al., “GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects,” Cell, vol. 142, no. 5, pp. 687–698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. R. L. Bradley, F. M. Fisher, and E. Maratos-Flier, “Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes,” Obesity, vol. 16, no. 5, pp. 938–944, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. YeopHan, A. Y. Kargi, M. Omer, C. K. Chan, M. Wabitsch, and K. D. O'Brien, “Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation,” Diabetes, vol. 59, no. 2, pp. 386–396, 2010. View at Publisher · View at Google Scholar
  17. J. Zhang, L. S. Barak, K. E. Winkler, M. G. Caron, and S. S. G. Ferguson, “A central role for β-arrestins and clathrin-coated vesicle-mediated endocytosis in β2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types,” The Journal of Biological Chemistry, vol. 272, no. 43, pp. 27005–27014, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. A. McNicholas, J. D. Dean, H. Mulder, C. Carnegie, and N. A. Jones, “A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function,” BJU International, vol. 91, no. 1, pp. 69–74, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. P. Godard, B. A. Johnson, and S. R. Richmond, “Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men,” Obesity Research, vol. 13, no. 8, pp. 1335–1343, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. E. Atkinson, E. S. Maywood, J. E. Chesham et al., “Cyclic AMP signaling control of action potential firing rate and molecular circadian pacemaking in the suprachiasmatic nucleus,” Journal of Biological Rhythms, vol. 26, no. 3, pp. 210–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. Ballard, L. Trout, J. Garrison, and S. K. Inglis, “Ionic mechanism of forskolin-induced liquid secretion by porcine bronchi,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 290, no. 1, pp. L97–L104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-L. Cao, V. F. Vialou, M. K. Lobo et al., “Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 39, pp. 17011–17016, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. I. V. Sokolova, H. A. Lester, and N. Davidson, “Postsynaptic mechanisms are essential for forskolin-induced potentiation of synaptic transmission,” Journal of Neurophysiology, vol. 95, no. 4, pp. 2570–2579, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Arsenijevic, F. Grégoire, V. Delforge, C. Delporte, and J. Perret, “Murine 3T3-L1 Adipocyte cell differentiation model: validated reference genes for qPCR gene expression analysis,” PLoS ONE, vol. 7, no. 5, Article ID e37517, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Arsenijevic, F. Gregoire, J. Chiadak et al., “Pituitary Adenylate Cyclase Activating Peptide (PACAP) participates in adipogenesis by activating ERK signaling pathway,” PLoS ONE, vol. 8, no. 9, Article ID e72607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, no. 7, 2002. View at Google Scholar
  29. K. M. Ajuwon and M. E. Spurlock, “Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 288, no. 5, pp. R1220–R1225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. K. M. Ajuwon, W. Banz, and T. A. Winters, “Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes,” Journal of Inflammation, vol. 6, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Zoico, U. Garbin, D. Olioso et al., “The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: Role of the NF-κB pathway,” International Journal of Molecular Medicine, vol. 24, no. 6, pp. 847–851, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Miyamoto, P. J. Chiao, and I. M. Verma, “Enhanced IκBα degradation is responsible for constitutive NF-κB activity in mature murine B-cell lines,” Molecular and Cellular Biology, vol. 14, no. 5, pp. 3276–3282, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. A. J. Alonso-Castro, R. Zapata-Bustos, G. Gómez-Espinoza, and L. A. Salazar-Olivo, “Isoorientin reverts TNF-α-induced insulin resistance in adipocytes activating the insulin signaling pathway,” Endocrinology, vol. 153, no. 11, pp. 5222–5230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. E. Davis, N. K. Gabler, J. Walker-Daniels, and M. E. Spurlock, “Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat,” Obesity, vol. 16, no. 6, pp. 1248–1255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. M. Cooper, “Protein degradation,” in The Cell: A Molecular Approach, Sinauer Associates, Sunderland, Mass, USA, 2nd edition, 2000. View at Google Scholar
  36. K. Eguchi, I. Manabe, Y. Oishi-Tanaka et al., “Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation,” Cell Metabolism, vol. 15, no. 4, pp. 518–533, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, pp. 335–376, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. M. Cranmer-Byng, D. M. Liddle, A. A. De Boer, J. M. Monk, and L. E. Robinson, “Proinflammatory effects of arachidonic acid in a lipopolysaccharide-induced inflammatory microenvironment in 3T3-L1 adipocytes in vitro,” Applied Physiology, Nutrition, and Metabolism, vol. 40, no. 2, pp. 142–154, 2015. View at Publisher · View at Google Scholar
  39. P. Ghersa, R. H. Van Huijsduijnen, J. Whelan, Y. Cambet, R. Pescini, and J. F. DeLamarter, “Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway,” Journal of Biological Chemistry, vol. 269, no. 46, pp. 29129–29137, 1994. View at Google Scholar · View at Scopus
  40. M. Neumann, T. Grieshammer, S. Chuvpilo et al., “RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A,” EMBO Journal, vol. 14, no. 9, pp. 1991–2004, 1995. View at Google Scholar · View at Scopus
  41. P. Farmer and J. Pugin, “Beta-adrenergic agonists exert their ‘anti-inflammatory’ effects in monocytic cells through the IkappaB/NF-kappaB pathway,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 279, no. 4, pp. L675–L682, 2000. View at Google Scholar · View at Scopus
  42. S. Ghosh and D. Baltimore, “Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB,” Nature, vol. 344, no. 6267, pp. 678–682, 1990. View at Publisher · View at Google Scholar · View at Scopus
  43. S.-C. Sun, P. A. Ganchi, D. W. Ballard, and W. C. Greene, “NF-κb controls expression of inhibitor iκBα: evidence for an inducible autoregulatory pathway,” Science, vol. 259, no. 5103, pp. 1912–1915, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Krappmann, F. G. Wulczyn, and C. Scheidereit, “Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo,” EMBO Journal, vol. 15, no. 23, pp. 6716–6726, 1996. View at Google Scholar · View at Scopus
  45. E. Mathes, E. L. O'Dea, A. Hoffmann, and G. Ghosh, “NF-κB dictates the degradation pathway of IκBα,” The EMBO Journal, vol. 27, no. 9, pp. 1357–1367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. G. C. N. Parry and N. Mackman, “role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription,” Journal of Immunology, vol. 159, no. 11, pp. 5450–5456, 1997. View at Google Scholar · View at Scopus
  47. V. Ollivier, G. C. Parry, R. R. Cobb, D. de Prost, and N. Mackman, “Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells,” Journal of Biological Chemistry, vol. 271, no. 34, pp. 20828–20835, 1996. View at Publisher · View at Google Scholar · View at Scopus